Citation Impact
Citing Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer
1997
Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia.
1999
Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer
2000
Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors
1999
Hallmarks of Cancer: The Next Generation
2011 Standout
Bone marrow-derived mesenchymal stem cells and the tumor microenvironment
2010
Modulation by verapamil of vincristine pharmacokinetics and toxicity in mice bearing human tumor xenografts
1989
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
2009 StandoutNobel
The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis
2002
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
1994 Standout
Overexpression of vascular endothelial growth factor and its receptors in bronchial dypslasia demonstrated by quantitative RT-PCR analysis
2004
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
Epidermal growth factor-related peptides and their receptors in human malignancies
1995 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Inactivation of the DNA-Repair GeneMGMTand the Clinical Response of Gliomas to Alkylating Agents
2000 Standout
Lung Cancer
2008 Standout
Ranibizumab for Neovascular Age-Related Macular Degeneration
2006 Standout
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
2009 StandoutNobel
Involvement of endothelial progenitor cells in tumor vascularization
2010
New insights into nNOS regulation of vascular homeostasis
2005 StandoutNobel
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
2006 Standout
When Checkpoints Fail
1997 StandoutNobel
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
2006 StandoutNobel
Insulin-like Growth Factor 1 Induces Hypoxia-inducible Factor 1-mediated Vascular Endothelial Growth Factor Expression, Which is Dependent on MAP Kinase and Phosphatidylinositol 3-Kinase Signaling in Colon Cancer Cells
2002 StandoutNobel
Epigenetics in Cancer
2008 Standout
Age-dependent Defect in Vascular Endothelial Growth Factor Expression Is Associated with Reduced Hypoxia-inducible Factor 1 Activity
2000 StandoutNobel
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Vascular Endothelial Growth Factor: Molecular and Biological Aspects
1999
Angiogenesis in life, disease and medicine
2005 StandoutNature
Molecular and biological properties of vascular endothelial growth factor
1999
VEGF and bFGF are highly expressed in intraluminal fibromyxoid lesions in bronchiolitis obliterans organizing pneumonia
2001
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
Primer‐dependent Amplification of mdr1 mRNA by Polymerase Chain Reaction
1992
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
Oxidants, oxidative stress and the biology of ageing
2000 StandoutNature
Vascular-specific growth factors and blood vessel formation
2000 StandoutNature
A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer
2003 Standout
Elusive Identities and Overlapping Phenotypes of Proangiogenic Myeloid Cells in Tumors
2010
Tobacco Smoke Carcinogens and Lung Cancer
1999 Standout
Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma
1998
Complementation of the xeroderma pigmentosum DNA repair synthesis defect withEscherichia coliUvrABC proteins in a cell-free system
1990 StandoutNobel
Genetic analysis of ageing: role of oxidative damage and environmental stresses
1996
Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets?
2003
Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1α
1998 StandoutNobel
Gene-expression profiles predict survival of patients with lung adenocarcinoma
2002 Standout
Serum Vascular Endothelial Growth Factor in Epithelial Ovarian Neoplasms: Correlation with Patient Survival
1999
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Repair of O6-alkylguanine by alkyltransferases
2000
Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels
1997
Progress in understanding the molecular pathogenesis of human lung cancer
1998
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
2004 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Carbon Monoxide and Nitric Oxide Suppress the Hypoxic Induction of Vascular Endothelial Growth Factor Gene via the 5′ Enhancer
1998 StandoutNobel
Angiogenesis as a therapeutic target
2005 StandoutNature
Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor
1998 Standout
The p66shc adaptor protein controls oxidative stress response and life span in mammals
1999 StandoutNature
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
2005 Standout
Restoration of u.v.-induced excision repair in Xeroderma D cells transfected with the denV gene of bacteriophage T4.
1987
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I.
1998
Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival.
2001
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
1991 StandoutScience
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis.
2002
Redefining the Target: Chemotherapeutics as Antiangiogenics
2001
VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours
1999
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
The Biology of Vascular Endothelial Growth Factor
1997 Standout
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
1999 StandoutScience
Preclinical Safety Evaluation of rhuMAbVEGF, an Antiangiogenic Humanized Monoclonal Antibody
1999
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.
2000
Cloning and characterization of a functional human homolog of Escherichia coli endonuclease III
1997 StandoutNobel
Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.
1997
Liver tumors distinguished by immunofluorescence microscopy with antibodies to proteins of intermediate-sized filaments.
1980
HIF-1 and human disease: one highly involved factor
2000 StandoutNobel
Immunogenic (tum−) variants obtained by mutagenesis of mouse mastocytoma P815
1987
Mechanism of action of hydroxyurea.
1992
The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells
1982 Standout
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
1992 StandoutScience
Works of J Mattern being referenced
Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma
1996
Heat shock (hsp70) and resistance proteins in non-small cell lung carcinomas
1995
VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma
2008
Prognostic value of basic fibroblast growth factor and its receptor (FGFR-1) in patients with non-small cell lung carcinomas
1997
Smoking-related increase of O6-methylguanine-DNA methyltransferase expression in human lung carcinomas
1998
Occurrence of a multidrug-resistant phenotype in human lung xenografts
1987
P-Glycoprotein expression in treated and untreated human breast cancer
1989
Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells.
1994
PD-ECGF, bFGF, and VEGF expression in non-small cell lung carcinomas and their association with lymph node metastasis.
1999
Immunocytochemical detection of a resistance-associated glycoprotein in tissue culture cells, ascites tumors and human tumor xenografts by Mab 265/F4.
1988
Use of gene transfer and a novel cosmid rescue strategy to isolate transforming sequences.
1985
Vascular Liver Tumors Induced in <italic>Mastomys(Praomys) natalensis </italic> by Single or twofold administration of DimethyInitrosamine
1979
Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationships to drug response in vitro.
1997
Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density.
1997
Microvessel density and vascular endothelial growth factor expression in human tumors of different localization
1996
Optimum time sequence for the administration of cyclophosphamide and other drugs in vivo.
1985
Up-regulation of heat shock protein 70 in adenocarcinomas of the lung in smokers.
1996
Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations
1993
Therapy of solid Walker carcinosarcoma 256 with bleomycin after synchronization with hydroxyurea
1980
VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION AND ANGIOGENESIS IN NONSMALL CELL LUNG CARCINOMAS
1995